54.82 -0.12 (-0.22%)
NVS
Stock Details
Last Trade:54.82 Change:-0.12 (-0.22%) Prev Close:54.94 Open: 54.82 Days Range:54.58 – 54.96 52 Week Range: 35.20 - 56.42 Volume:1316631 P/E: N/AEPS:0.00
View AllRecent Alerts 03/19/10
Recent Alert on 03/15/10 at 7:33am
Novartis (NVS) Announces Positive Data in Valsartan Phase 2
Novartis (NVS) Announces Positive Data in Valsartan Phase 2
Results from a landmark study involving more than 9,000 people showed that Novartis' (NYSE: NVS) high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired... Read More
Recent Alert on 03/10/10 at 8:35am
Hapoalim Securities Initiates Coverage on Vanda Pharmaceuticals (VNDA) with a Buy; Attractive Entry Point
Hapoalim Securities Initiates Coverage on Vanda Pharmaceuticals (VNDA) with a Buy; Attractive Entry Point
Recent Alert on 02/22/10 at 7:16am
Novartis (NVS) Receives U.S. FDA Approval for Meningoccoccal Treatment Menveo
Novartis (NVS) Receives U.S. FDA Approval for Meningoccoccal Treatment Menveo
Recent Alert on 02/22/10 at 7:16am
Novartis (NVS) Receives U.S. FDA Approval for Meningoccoccal Treatment Menveo
Novartis (NVS) Receives U.S. FDA Approval for Meningoccoccal Treatment Menveo
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 03/18/10 at 3:25am
High Conviction: The Dominant Generic Drugmaker Will Widen Its Lead
High Conviction: The Dominant Generic Drugmaker Will Widen Its Lead
Blog Posts on 03/16/10 at 7:21am
Vanda, Titan Pharmaceuticals: 2 Biotech Stocks It Wouldn't Hurt to Own
Vanda, Titan Pharmaceuticals: 2 Biotech Stocks It Wouldn't Hurt to Own